Basic Information
Trestle Biotherapeutics is a biotechnology company introducing bioengineered kidneys for patients with kidney disease. Trestle is developing an implantable therapeutic tissue that will be provided to patients with end-stage renal disease (ESRD).
Trestle Biotherapeutics
California,United States of America
less than 15 people
January 01, 2020
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios